| Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy Y Lu, YT Chan, HY Tan, S Li, N Wang, Y Feng Molecular cancer 19, 1-16, 2020 | 421 | 2020 |
| Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma Y Lu, YT Chan, HY Tan, C Zhang, W Guo, Y Xu, R Sharma, ZS Chen, ... Journal of Experimental & Clinical Cancer Research 41, 1-17, 2022 | 137 | 2022 |
| Lysyl oxidase‐like 4 fosters an immunosuppressive microenvironment during hepatocarcinogenesis HY Tan, N Wang, C Zhang, YT Chan, MF Yuen, Y Feng Hepatology 73 (6), 2326-2341, 2021 | 87 | 2021 |
| The role of AMP-activated protein kinase as a potential target of treatment of hepatocellular carcinoma X Jiang, HY Tan, S Teng, YT Chan, D Wang, N Wang Cancers 11 (5), 647, 2019 | 66 | 2019 |
| GPC2 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer G Chen, D Luo, N Zhong, D Li, J Zheng, H Liao, Z Li, X Lin, Q Chen, ... Frontiers in immunology 13, 857308, 2022 | 55 | 2022 |
| The toxicology and detoxification of Aconitum: traditional and modern views YT Chan, N Wang, Y Feng Chinese Medicine 16, 1-14, 2021 | 52 | 2021 |
| Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era? YT Chan, N Wang, HY Tan, S Li, Y Feng Frontiers in pharmacology 11, 548, 2020 | 47 | 2020 |
| CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives YT Chan, Y Lu, J Wu, C Zhang, HY Tan, Z Bian, N Wang, Y Feng Theranostics 12 (7), 3329, 2022 | 46 | 2022 |
| PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma N Wang, HY Tan, Y Lu, YT Chan, D Wang, W Guo, Y Xu, C Zhang, F Chen, ... Signal Transduction and Targeted Therapy 6 (1), 86, 2021 | 46 | 2021 |
| The functional role of long noncoding RNA in resistance to anticancer treatment Y Qu, HY Tan, YT Chan, H Jiang, N Wang, D Wang Therapeutic advances in medical oncology 12, 1758835920927850, 2020 | 43 | 2020 |
| Multi-component Chinese medicine formulas for drug discovery: state of the art and future perspectives C Zhang, G Chen, G Tang, X Xu, Z Feng, Y Lu, YT Chan, J Wu, Y Chen, ... Acta Materia Medica 2 (1), 106-125, 2023 | 37 | 2023 |
| ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis HY Tan, N Wang, YT Chan, C Zhang, W Guo, F Chen, Z Zhong, S Li, ... Cancer Letters 475, 109-118, 2020 | 30 | 2020 |
| The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma J Wu, YT Chan, Y Lu, N Wang, Y Feng Medicinal Research Reviews 43 (6), 1946-1973, 2023 | 24 | 2023 |
| Ancient Chinese medicine herbal formula Huanglian Jiedu Decoction as a neoadjuvant treatment of chemotherapy by improving diarrhea and tumor response YT Chan, F Cheung, C Zhang, B Fu, HY Tan, H Norimoto, N Wang, ... Frontiers in Pharmacology 11, 252, 2020 | 24 | 2020 |
| Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient … N Wang, HY Tan, YT Chan, W Guo, S Li, Y Feng Oncotarget 8 (62), 105848, 2017 | 24 | 2017 |
| Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC YT Chan, J Wu, Y Lu, Q Li, Z Feng, L Xu, H Yuan, T Xing, C Zhang, ... Molecular Cancer 23 (1), 74, 2024 | 19 | 2024 |
| Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis Y Chan, H Tan, Y Lu, C Zhang, C Cheng, J Wu, N Wang, Y Feng Acta Pharmaceutica Sinica B 13 (4), 1554-1567, 2023 | 19 | 2023 |
| CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress Y Lu, YT Chan, J Wu, Z Feng, H Yuan, Q Li, T Xing, L Xu, C Zhang, ... Drug Resistance Updates 71, 101015, 2023 | 18 | 2023 |
| Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma YT Chan, C Zhang, J Wu, P Lu, L Xu, H Yuan, Y Feng, ZS Chen, N Wang Molecular Cancer 23 (1), 189, 2024 | 15 | 2024 |
| The role of protein SUMOylation in human hepatocellular carcinoma: A potential target of new drug discovery and development H Yuan, Y Lu, YT Chan, C Zhang, N Wang, Y Feng Cancers 13 (22), 5700, 2021 | 14 | 2021 |
